An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents β-aminopropionitrile monofumarate-induced aortic dissection in rats

Journal of Vascular Surgery

Volumn 36, Issue 4, 2002, Pages 818-823

  Nagashima, Hirotaka ^a,b   Uto, Kento ^a,b   Sakomura, Yasunari ^a,b   Aoka, Yoshikazu ^a,b   Sakuta, Akiko ^a,b   Aomi, Shigeyuki ^a,b   Hagiwara, Nobuhisa ^a,b   Kawana, Masatoshi ^a,b   Kasanuki, Hiroshi ^a,b  

^a Tokyo Women's Medical University ^*

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPIONITRILE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OLMESARTAN; TEMOCAPRIL; TRANSCRIPTASE; 3 AMINOPROPIONITRILE FUMARATE; ANGIOTENSIN RECEPTOR; BETA-AMINOPROPIONITRILE FUMARATE; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE; THIAZEPINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISSECTION; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HISTOPATHOLOGY; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA ANEURYSM; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DISSECTING ANEURYSM; DRUG ANTAGONISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

AMINOPROPIONITRILE; ANEURYSM, DISSECTING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTIC ANEURYSM; DISEASE MODELS, ANIMAL; IMIDAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TETRAZOLES; THIAZEPINES;

EID: 0036781239     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.126091     Document Type: Article

References (19)

1. Carlson RG, Lillehei CW, Edwards JE. Cystic medial necrosis of the ascending aorta in relation to age and hypertension. Am J Cardiol 1970;25:411-5.
2. Schlatmann TJ, Becker AE. Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol 1977; 39:13-20.
3. Nagashima H, Sakomura Y, Aoka Y, Uto K, Kameyama K, Ogawa M, et al. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marian's syndrome. Circulation 2001;104:I-282-7.
4. Nakashima Y, Sueishi K. Alteration of elastic architecture in the lathyritic rat aorta implies the pathogenesis of aortic dissecting aneurysm. Am J Pathol 1992;140:959-69.
5. Bruel A, Ortoft G, Oxlund H. Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. Atherosclerosis 1998;140:135-45.
6. Kumar D, Trent MB, Boor PJ. Allylamine and b-aminopropionitrile induced aortic medial necrosis: mechanisms of synergism. Toxicology 1998;125:107-15.
7. Daugherty A, Manning WM, Cassis L. Angiotensin II promotes atherosclerotic lesions and aneurysm in apolipoprotein E-deficient mice. J Clin Invest 2000;105:1605-12.
8. Nishijo N, Sugiyama F, Kimoto K, Taniguchi K, Murakami K, Suzuki S, et al. Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II. Lab Invest 1998;78:1059-66.
9. Daugherty A, Cassis L. Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Ann N Y Acad Sci 1999;892:108-18.
10. Liao S, Miralles M, Kelley BJ, Curci JA, Borhani M, Thompson RW. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001;33:1057-64.
11. Stroth U, Linger T. The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol 1999;33(Suppl I):S21-8.
12. Horiuchi M, Akishita M, Dzau VJ. Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr Res 1998;24:307-14.
13. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996;93: 156-60.
14. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest 1991; 88:921-33.
15. Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H, Diamant D, et al. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 1994;267:H844-52.
16. Snog K, Shiota N, Takai S, Takashima H, Iwasaki H, Kim S, et al. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys. Atherosclerosis. 1998;138:171-82.
17. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y, et al. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 1998;32:467-72.
18. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M, et al. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995;95:46-54.
19. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582-7.